Regulation of Contraction in Cardiac Muscle Is Also Actin-Based
Cardiac muscle, like skeletal muscle, is striated. It also is regulated by a similar actin-myosin-tropomyosin-troponin system. Unlike skeletal muscle, cardiac muscle exhibits intrinsic rhythmicity, and individual myocytes communicate with each other because of its syncytial nature. The T-tubular system is more developed in cardiac muscle, whereas the SR is less extensive and consequently the intracellular supply of Ca2+ for contraction is lower. Cardiac muscle thus relies on extracellular Ca2+ for contraction; if isolated cardiac muscle is deprived of Ca2+, it ceases to beat within approximately 1 minute, whereas skeletal muscle can continue to contract without an extracellular source of Ca2+ for a longer period. Cyclic AMP (cAMP) plays a more prominent role in cardiac muscle than it does in skeletal muscle. cAMP modulates intracellular levels of Ca2+ through the activation of the protein kinases that phosphorylate various transport proteins in the sarcolemma and SR. The protein kinases also target the troponin-tropomyosin regulatory complex, affecting its responsiveness to intracellular Ca2+. There is a rough correlation between the phosphorylation of TpI and the increased contraction of cardiac muscle induced by catecholamines. This may account for the inotropic effects (increased contractility) of β-adrenergic compounds on the heart. Some differences among skeletal, cardiac, and smooth muscle are summarized in Table 1.

Table1. Some Differences Among Skeletal, Cardiac, & Smooth Muscle
Ca2+ Enters Cardiomyocytes via Ca2+ Channels & Leaves via the Na+-Ca2+ Exchanger & the Ca2+ ATPase
Extracellular Ca2+ enters cardiomyocytes via highly selective channels. The major portal of entry is the L-type (long-duration current, large conductance) or slow Ca2+ channel, which is voltage-gated, opening during depolarization and closing when the action potential declines. These channels are equivalent to the dihydropyridine receptors of skeletal muscle. Slow Ca2+ channels are regulated by cAMP-dependent protein kinases (stimulatory) and cGMP-dependent protein kinases (inhibitory), and can be inhibited by so-called calcium channel blockers (eg, verapamil). Fast (or T, transient) Ca2+ channels are also present in the plasmalemma, though in much lower numbers; they probably contribute to the early phase of increase of myoplasmic [Ca2+].
When the [Ca2+] in the myoplasm increases, it triggers the opening of the Ca2+ release channel of the SR. This Ca2+ induced Ca2+ release from the SR stores accounts for approximately 90% of the Ca2+ that enters a stimulated cardiomyocyte. However, the 10% that enters from the cytoplasm is vitally important, as it serves as a trigger for mobilization of Ca2+ from the SR.
The Na+-Ca2+ exchanger serves as the principal route of egress of Ca2+ from cardiomyocytes. Na+ and Ca2+ are exchanged at a ratio of 3:1, with movement of Na+ into the cell from the plasma providing the energy needed to move Ca2+ into the plasma against a concentration gradient. The Na+ Ca2+ exchange contributes to relaxation, but may run in the reverse direction during excitation. Consequently, anything that causes intracellular [Na+] to rise will secondarily cause intracellular [Ca2+] to rise as well, causing more forceful con traction (positive inotropic effect). Digitalis promotes the inflow of Ca2+ via the Ca2+-Na+ exchanger by inhibiting the sarcolemmal Na+-K+-ATPase, reducing the rate of Na+ exit by this route, thereby increasing intracellular [Na+]. The resulting increase in intracellular [Ca2+] enhances the force of cardiac contraction to the benefit of a patient experiencing heart failure (Figure 1).

Fig1. Scheme of how the drug digitalis (used in the treatment of certain cases of heart failure) increases cardiac contraction. Digitalis inhibits the Na+-K+ ATPase (see Chapter 40). This results in less Na+ being pumped out of the cardiac myocyte and leads to an increase of the intracellular [Na+]. In turn, this stimulates the Na+-Ca2+ exchanger so that more Na+ is exchanged outward, and more Ca2+ enters the myocyte. The resulting increased intracellular [Ca2+] increases the force of muscular contraction.
In contrast to skeletal muscle, the sarcolemmal Ca2+ ATPase is a to be a minor contributor to Ca2+ egress as com pared with the Ca2+-Na+exchanger. Ion channels are important in skeletal muscle, as well as in cardiac muscle (see Chapter 40). Mutations in genes encoding ion channels are responsible for a number of relatively rare conditions affecting muscle. These and other diseases due to mutations of ion channels have been termed channelopathies; some are listed in Table 2.

Table2. Some Disorders (Channelopathies) due to Mutations in Genes Encoding Polypeptide Constituents of Ion Channels